On April 18, 2019, the Canadian International Trade Tribunal (CITT) determined that the dumping of Nitisinone Capsules with a dosage of 2 mg, 5 mg, 10 mg and 20 mg, whether or not they are packaged for retail sale, originating in or exported from Sweden has not caused injury or retardation, nor threatens to cause injury to the Canadian domestic industry. Consequently, the CITT has terminated its inquiry.
This follows the CBSA Notice of Final Determination made on March 20, 2019.
The subject goods are usually classified under HS classification numbers: 3004.90.00.79, 3004.90.00.90 or 3003.90.00.90. These classification numbers are provided for ease of reference only. Refer to the product definition for the authoritative details regarding the subject goods.
The statement of reasons containing additional details of the determination will be posted on CITT’s website within 15 days
Additional Information is contained in the CITT finding available on CITT’s website.